Non-Vascular Stents Market

Global Non-Vascular Stents Market Size (2022 to 2027)

The global non-vascular stents market size is estimated to be worth USD 1268.5 million by 2027 from USD 970.6 million in 2022, growing at a CAGR of 5.5% during the forecast period.

Global Non-Vascular Stents Market Share Insights:

• Based on type, the gastrointestinal stents segment accounted for the largest non-vascular stents market share in 2021.
• Geographically, the North American region had the most dominating share of the global market in 2021.
• The European region is expected to be worth USD 351.1 million by 2027.
• The Asia-Pacific region is predicted to rise at a CAGR of 6% from 2022 to 2027.

Stents are tubes or devices placed in the body to generate a passage between hollow spaces, and stenting is the process of placement of such a stent in the body. Non-vascular stents are usually utilized for making a pathway in vessels of the body, particularly the arteries and veins that carry lymph and blood.

MARKET DRIVERS:

The increasing disease prevalence of cancer and urolithiasis primarily drives the growth of non-vascular stents.

As per the American Cancer Society, 1.9 million new cancer cases and 609360 cancer deaths are expected in the United States in 2022. The growing number of people suffering from urological and gastrointestinal diseases and the increasing application of non-vascular stents in various emerging fields, such as ophthalmic and neural sciences, are further expected to promote the growth of non-vascular stents. The rising demand for less invasive techniques decreases hospital stays, and diminishing the threat of contracting hospital-acquired infections propels the market growth. In the United States, kidney disorders kill more people than prostate cancer or breast cancer each year. An estimated 34500 people die from prostate cancer yearly in the United States, whereas approximately 43780 people die from breast cancer. The growing adoption of the latest technologies to develop stents and retrieval, growing demand for minimally invasive surgeries, and patients due to less-cost and less procedural time amid the ambulatory surgical centers are projected to boost the growing demand for non-vascular stents market growth. More than 1 million abdominal wall hernia repairs are implemented annually in the U.S., along with inguinal hernias representing around 77,000 cases. About 90% of inguinal hernia repairs are executed in males. As per WHO, 3 million people and above die yearly from chronic obstructive pulmonary diseases (COPD) worldwide, and 90% of the deaths are from low and middle-income countries.

In addition, the growing adoption of technological advancements in the healthcare sector, YOY growth in the geriatric population, and increased life expectancy are anticipated to boost the market’s growth rate during the forecast period. According to the World Health Organization (WHO), one in every six people is expected to be older than 60 or more by 2030. As a result, the aging population is likely to get diagnosed with various diseases, which is anticipated to result in a greater need for non-vascular stents.

MARKET RESTRAINTS:

However, stringent regulatory systems and high costs associated with non-vascular stents are expected to limit the adoption and negatively impact market growth. In addition, the availability of alternative options for relieving luminal structures further limits the market’s growth rate.

Impact of COVID-19 on the global non-vascular stents market:

The unexpected outburst of COVID COVID-19ly changed into a pandemic of unforeseen situations. The change has shifted the focus of the world towards the healthcare sector. Worldwide, governments and other healthcare organizations are effectively working with healthcare institutions and pharmaceutical companies to provide efficient treatment for patients suffering from infection. During the COVID-19 pandemic, less importance was given to elective surgeries, and more priority was given to COVID-19 patients, which resulted in the reduced demand for the non-vascular stent market. In addition, the disruptions in the supply chain ecosystem and stoppage in medical device manufacturing activities further impacted the market’s growth rate. Likewise, COVID-19 has shown a significant negative impact on the growth of the non-vascular stents market during the pandemic. However, due to the new normalization and reduced impact of COVID-19, the market is expected to recover quickly and register sharp growth during the forecast period.

REPORT COVERAGE:

This research report on global non-vascular stents has been segmented and sub-segmented based on the End User, Type, and Region.

Global Non-Vascular Stents Market – By Type:

• Pancreatic and Biliary Stents
  • Biliary Stents                       
    • Plastic Biliary Stents     
    • Metal Biliary Stents      
      • Metal Non-Covered Biliary Stents
      • Metal Partially Covered Biliary Stents
      • Metal Fully Covered Biliary Stents
  • Pancreatic Stents                              
    • Plastic Pancreatic Stents            
    • Metal Pancreatic Stents             
      • Metal Non-Covered Pancreatic Stents
      • Metal Fully Covered Pancreatic Stents
• Gastrointestinal Stents                                      
  • Fully Covered Gastrointestinal Stents                      
  • Partially Covered Gastrointestinal Stents                               
  • Non-Covered Gastrointestinal Stents                      
• Airway Stents                                        
  • Silicone Airway Stents                    
  • Metallic Airway Stents                    
    • Fully Covered Metallic Airway Stents   
    • Uncovered Metallic Airway Stents        
• Urinary Tract Stents                                            
  • Ureteral Stents                  
  • Metal Ureteral Stents                     
  • Polymer Ureteral Stents                
  • Bioabsorbable Ureteral Stents.                  
  • Prostate Stents                 
  • Metal Prostrate Stents                   
  • Polymer Prostrate Stents                              
  • Bioabsorbable Prostate Stents.                  
  • Urethral Stents                  
  • Metal Urethral Stents                  
  • Polymer Urethral Stents                             
  • Bioabsorbable Urethral Stents       

Based on the type, the gastrointestinal stents segment is expected to dominate the non-vascular stents market with the largest share during the forecast period. The segment's growth is driven by the growing incidence of gastrointestinal cancer, such as stomach cancer, small intestine, bowels, and liver, integrated with patients' climbing significance for minimally invasive surgeries.

The ureteral stents segment is expected to grow rapidly owing to the rising incidence of ureteral diseases, urinary tract infections, and prostate cancers worldwide. In addition, thee. The increasing number of ureteroscopy, lithotripsy, and other techniques worldwide augment the growth of the ureteral stents segment.

Global Non-Vascular Stents Market – By End User:

• Hospitals
• Ambulatory Surgical Centers
• Others

The hospital end-user segment is predicted to dominate the global non-vascular stents market during the forecast period. The increasing number of patients suffering from ureteral, gastrointestinal, and other chronic diseases is climbing the market growth. Moreover, the well-developed healthcare infrastructure, expanding sound knowledge among the patients regarding the patients' early diagnosis and treatment, bolsters the market growth.

Global Non-Vascular Stents Market – By Material:

• Metallic Stents
• Non-Metallic Stents

The metallic stents material holds the largest share in the non-vascular stents market during the forecast period. The escalating technology advancements are significant driving factors usage and wide applications of metallic stents coupled with advanced technologies surge the market growth expansion during the analysis period.

The non-metallic stents are the quickest-growing segment and are scheduled to record the highest CAGR growth rate during the period. The non-metallic stents, used for treating benign structures as they require less treatment time, less cost, and easy movement, make the market move forward.

Global Non-Vascular Stents Market – By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Regionally, the North American non-vascular stents market held a significant share in the global market in 2021 owing to the increasing prevalence of lung cancer, glaucoma, central airway obstruction, COPD, asthma, and other chronic diseases in the U.S. and Canada. In addition, the local presence of major market players, the target population, and the robust healthcare infrastructure in the region further supported this region's dominance.

The non-vascular stents market in Europe is also expected to hold a substantial market share during the forecast period due to the flourishing medical technology sector and the increasing prevalence of gastric cancer in the EU5 countries.

On the other hand, the non-vascular stents market in the Asia Pacific is expected to register a higher CAGR over the forecast period compared to other regions due to favorable government initiatives for using such medical devices, the rising geriatric population, and increasing healthcare expenditure.

The Latin American non-vascular stents market is expected to be worth USD 154 million by 2027.

The non-vascular stents market in MEA is anticipated to grow at a CAGR of 5.8% from 2022 to 2027.

KEY MARKET PARTICIPANTS:

Companies playing a leading role in the global non-vascular stents market profiled in this report are CONMED Corporation, Taewoong Medical Co., Medtronic; C. R. Bard, Inc.; Boston Scientific Corporation; HOBBS MEDICAL, INC; Cook Medical; ELLA - CS, s.r.o.; Ltd.; Synchron Med Inc.; and Glaukos Corporation.

RECENT HAPPENINGS IN THIS MARKET:

• In October 2020, Medtronic received FDA approval for its Abre venous self-expanding stent device to treat venous outflow obstruction.
• In January 2021, the Synergy Megatron Drug-Eluting system of Boston Scientific received U.S. Food and Drug Administration approval. The Synergy Megatron offers best-in-class radial and axial strength in maintaining strength integrity.